Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLM(R) Scale

Background: Cerebrospinal fluid (CSF) biomarkers (Aβ peptides and tau proteins) improved the diagnosis of Alzheimer’s disease (AD) in research and clinical settings. We previously described the PLM-scale (Paris-Lille-Montpellier study), which combines Aβ42, tau, and phosphorylated ptau(181) biomarke...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Aging Neurosci
Autores principales: Lehmann, Sylvain, Delaby, Constance, Boursier, Guilaine, Catteau, Cindy, Ginestet, Nelly, Tiers, Laurent, Maceski, Aleksandra, Navucet, Sophie, Paquet, Claire, Dumurgier, Julien, Vanmechelen, Eugeen, Vanderstichele, Hugo, Gabelle, Audrey
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2018
Materias:
Neuroscience
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5985301/
https://ncbi.nlm.nih.gov/pubmed/29892221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2018.00138
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares